QNRX vs QNTM

Quoin Pharmaceuticals, Ltd. vs Quantum Biopharma Ltd. — Valuation Comparison 2026

QNRX

Biotechnology
Quoin Pharmaceuticals, Ltd.
Quality
2.0
out of 10
Value Trap
Price
$4.94
Last close
Models
6/13
Active
VS

QNTM

Biotechnology
Quantum Biopharma Ltd.
Quality
1.8
out of 10
Value Trap
Price
$7.02
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType QNRX Fair ValueQNRX Upside QNTM Fair ValueQNTM Upside
Bayesian DCF Intrinsic $1.31 -73.5% $1.86 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $4.38 -12.4% $0.89 -88.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $4.33 -47.2%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for QNRX vs QNTM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

QNRX vs QNTM — Which Stock Is More Undervalued?

QNRX scores higher with a 2.0/10 quality rating vs QNTM's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Quoin Pharmaceuticals, Ltd. (QNRX) and Quantum Biopharma Ltd. (QNTM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

QNRX currently trades at $4.94 with a QOC of 2.0/10, while QNTM trades at $7.02 with a QOC of 1.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).